Lumos Diagnostics Holdings Limited Stock
Equities
LDX
AU0000157091
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.057 AUD | -3.39% | -13.64% | -21.92% |
Sales 2022 | 11.63M 7.49M | Sales 2023 | 10.54M 6.78M | Capitalization | 2.27M 1.46M |
---|---|---|---|---|---|
Net income 2022 | -45M -28.97M | Net income 2023 | -8M -5.15M | EV / Sales 2022 | 1.68 x |
Net cash position 2022 | 784K 505K | Net Debt 2023 | 6.77M 4.36M | EV / Sales 2023 | 0.86 x |
P/E ratio 2022 |
-0.32
x | P/E ratio 2023 |
-0.19
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 69.71% |
1 day | +1.72% | ||
1 week | -13.24% | ||
Current month | -3.28% | ||
1 month | -9.23% | ||
3 months | -25.32% | ||
6 months | -37.23% | ||
Current year | -19.18% |
Managers | Title | Age | Since |
---|---|---|---|
Douglas Ward
CEO | Chief Executive Officer | - | 22-06-20 |
Barrie Lambert
DFI | Director of Finance/CFO | - | 22-02-15 |
Sam Lanyon
CHM | Chairman | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lawrence Mehren
BRD | Director/Board Member | 57 | 20-10-31 |
Bronwyn Le Grice
BRD | Director/Board Member | - | 20-10-31 |
Douglas Ward
CEO | Chief Executive Officer | - | 22-06-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 0.057 | -3.39% | 938 858 |
24-04-17 | 0.059 | +1.72% | 624,905 |
24-04-16 | 0.058 | -3.33% | 2,560,222 |
24-04-15 | 0.06 | -4.76% | 1,790,223 |
24-04-12 | 0.063 | -4.55% | 922,102 |
Delayed Quote Australian S.E., April 17, 2024 at 02:10 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.18% | 17.89M | |
-0.50% | 12.75B | |
-19.65% | 6.89B | |
-2.87% | 4.95B | |
-7.82% | 4.28B | |
-0.84% | 4.23B | |
-47.89% | 3.67B | |
+8.57% | 2.62B | |
-6.37% | 2.31B | |
-2.61% | 1.7B |
- Stock Market
- Equities
- LDX Stock